The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
about
Fibronectin Mechanobiology Regulates TumorigenesisEDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against CancerAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedMechanisms of action of therapeutic antibodies for cancerIBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CACCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodelingTissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasionIrigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells.Fibronectin-guided migration of carcinoma collectivesAntibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic targetUbiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat.Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin.DAMPening inflammation by modulating TLR signalling.Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancerThe TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccineGlycosylation profiles determine extravasation and disease-targeting properties of armed antibodiesTreponema pallidum subsp. pallidum TP0136 protein is heterogeneous among isolates and binds cellular and plasma fibronectin via its NH2-terminal end.FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis.MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.Fibronectin splice variation in human knee cartilage, meniscus and synovial membrane: observations in osteoarthritic knee.Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancerGene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.Alternative splicing and tumor progression.High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models.Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.Plasma and cellular fibronectin: distinct and independent functions during tissue repair.Purification of Human Plasma/Cellular Fibronectin and Fibronectin Fragments.Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic TargetingGeneration and tumor recognition properties of two human monoclonal antibodies specific to cell surface anionic phospholipids.The Regulation of TGFβ1 Induced Fibronectin EDA Exon Alternative Splicing in Human Renal Proximal Tubule Epithelial Cells.The revival of cancer vaccines - The eminent need to activate humoral immunity.Evaluation of antibody-chemokine fusion proteins for tumor-targeting applications.
P2860
Q26768515-EED5AFA5-64E5-4670-828C-ED5508F6731CQ27340196-6047AA1C-AF5A-410D-BD50-95C9132FE7CDQ28297381-3D469AB7-3552-45CE-A8C0-52396CCD7BF9Q28385366-E2D1B24C-56C0-4A90-A809-44696B06C8E8Q28660580-4F65F3BD-1A10-4936-BA04-B6350B9D30C1Q30542261-17BBD5B4-CDA2-42AE-9A58-D8ED5FAA37C8Q30553128-C25C77C3-9BA9-46D6-BBC5-D30761E1B855Q30828838-E08CCC2B-F939-46E6-9F6D-556BA4A75D67Q30835803-EC00E082-0873-42E8-B8DB-7B6DBD9A21B7Q33396791-973A5D53-9236-4BC3-A40F-2FA3E4AD6946Q33560353-86D7799F-242C-462E-9A80-16B53E1D4C45Q33605532-275BC54E-3B16-492F-A0BF-9766E15EB455Q33706671-CD8D28C6-7246-4A96-8D48-8B531655EBF3Q34035570-C8495DA8-16B6-4612-B363-C833B5B7A45EQ35068030-19908266-3408-4B98-8847-DDBB6EED298AQ35113904-AFAAE7CD-35B5-4AEC-8217-56B7785352D9Q35129041-C70D5B9A-1458-4129-9F8B-E8F5162AD02BQ35203170-52C210E3-C0A4-42B5-B718-9C9166893B0AQ35551588-82B0E39B-5050-42B1-B8E4-33EC7E49EB42Q35740083-54FC7ECE-C0EF-499A-BD86-B3A3E9E883B3Q35904797-EED406AE-FA4B-44E4-B4DC-2E3DA11D3A96Q36018529-B8E0EA7D-E36B-4003-ADB1-4625EB375254Q36100821-408FD107-5CCC-49A0-B74F-8C27D0436DFAQ36547455-E486524C-C637-417A-A0D7-6EC91CB94AB0Q37046800-4EBD1187-C33A-40AE-8F8D-A04DBC520536Q37222930-EEB29B9A-1A88-4C74-915A-F1AD36C8FAD5Q37419228-347EFFA1-B856-483B-8E50-50AD980859D5Q37485709-C6705AA7-60D2-4395-81C4-A6DD166F2613Q37559740-FBB2EFBF-D815-4217-ABCB-AEB240B0B1EBQ37566991-61945F2C-B860-4C3A-9876-63660E371211Q37893598-989BD01C-321D-40D6-80A6-57C056D9E20BQ38196396-81B6F702-78AA-44B6-9A5C-F319033CF920Q38590521-C3C0A729-9D40-4624-9FA0-03F1F609DB81Q38694297-C1D306A0-B30D-4CD1-BF99-BDC11A194712Q38704265-B510039A-13DB-45F5-B8BD-0049BEA19A34Q38736395-3D157F77-491D-47C2-B719-7E4E701E6910Q38873741-F91C1F39-506C-480E-8CAC-9BAE14E150EFQ38981569-40D0D05F-176D-4FA1-A6CE-C322D6785C18Q39001905-9091C563-FC79-4B0E-B008-49DF8209DBE6Q39185087-B2632274-62E9-4DE9-93C1-64352C8FFDC3
P2860
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
description
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2007
@uk
name
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@en
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@nl
type
label
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@en
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@nl
prefLabel
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@en
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@nl
P2093
P1433
P1476
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
@en
P2093
Alessandra Villa
Jascha-N. Rybak
Manuela Kaspar
P304
10948-10957
P356
10.1158/0008-5472.CAN-07-1436
P407
P577
2007-11-15T00:00:00Z